tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
Advertisement

Ascendis Pharma (ASND) Technical Analysis

Compare
640 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 3.14, suggesting Ascendis Pharma is a Buy.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 196.01, while Ascendis Pharma’s (ASND) share price is $197.24, making it a Buy.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 188.25, while Ascendis Pharma’s (ASND) share price is $197.24, making it a Buy.

Ascendis Pharma (ASND) Pivot Points

Sep 18, 2025, 10:53 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
188.83
190.94
192.78
194.89
196.73
198.84
200.68
Fibonacci
190.94
192.45
193.38
194.89
196.40
197.33
198.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

Sep 18, 2025, 10:53 AM
Period
Simple
Exponential
MA5
196.71Buy
197.19Buy
MA10
199.58Sell
197.71Sell
MA20
196.88Buy
196.01Buy
MA50
185.79Buy
188.25Buy
MA100
176.66Buy
178.33Buy
MA200
159.48Buy
162.37Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 197.71, while Ascendis Pharma’s (ASND) share price is $197.24, making it a Sell.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 178.33, while Ascendis Pharma’s (ASND) share price is $197.24, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $197.24 and Ascendis Pharma’s (ASND) 50-day simple moving average is 185.79, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $197.24 and Ascendis Pharma’s (ASND) 100-day simple moving average is 176.66, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $197.24 and Ascendis Pharma’s (ASND) 200-day simple moving average is 159.48, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

Sep 18, 2025, 10:53 AM
Name
Value
Implied Action
RSI (14)
54.47
Neutral
STOCH (9,6)
18.07
Buy
STOCHRSI (14)
33.11
Neutral
MACD (12,26)
3.14
Buy
ADX (14)
26.33
Neutral
Williams %R
-64.35
Buy
CCI (14)
-21.76
Neutral
ATR (14)
6.48
-
Ultimate Oscillator
45.94
Neutral
ROC
0.29
Buy
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 54.47, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 26.33, creating a Neutral signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is -21.76, creating a Neutral signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is 0.29, creating a Buy signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Buy.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 54.47, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 3.14, which suggests ASND is a Buy.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 196.71, which suggests ASND is a Buy.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 196.88, which suggests ASND is a Buy.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 185.79, which suggests ASND is a Buy.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 159.48, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -64.35, which suggests ASND is a Buy.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is -21.76, which suggests ASND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis